Stay updated with breaking news from Mark Offerhaus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dutch/Swiss biotech company Micreos announced today it has secured its next funding round of €25 million in growth capital and for clinical development of its endolysin technology platform, set to replace
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
THE HAGUE, The Netherlands, Jan. 28, 2022 /PRNewswire/ -- Micreos announced that it has appointed Joost...
/PRNewswire/ -- Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely...
/PRNewswire/ -- Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely...